Variant report
Variant | esv3443318 |
---|---|
Chromosome Location | chr3:150536512-150541160 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs572233100 | chr3:150540286-150540287 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs541338474 | chr3:150540292-150540293 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs558072432 | chr3:150540334-150540335 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs191069799 | chr3:150540363-150540364 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs112496211 | chr3:150540416-150540417 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs546155149 | chr3:150540493-150540494 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs138487196 | chr3:150540505-150540506 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs368494113 | chr3:150540559-150540560 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs111925280 | chr3:150540563-150540564 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs561947596 | chr3:150540564-150540565 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs549504796 | chr3:150540609-150540610 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs62282685 | chr3:150540652-150540653 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs6803746 | chr3:150540658-150540659 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs547726002 | chr3:150540667-150540668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs374987461 | chr3:150540689-150540690 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs182171725 | chr3:150540699-150540700 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs78486547 | chr3:150540725-150540726 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs115088359 | chr3:150540734-150540735 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs369153300 | chr3:150540737-150540738 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs186773510 | chr3:150540770-150540771 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs535305841 | chr3:150540787-150540788 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs569519528 | chr3:150540893-150540894 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs191081353 | chr3:150540950-150540951 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs143342945 | chr3:150540951-150540952 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs58515064 | chr3:150541005-150541006 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs73871604 | chr3:150541015-150541016 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs183150575 | chr3:150541016-150541017 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs188033065 | chr3:150541048-150541049 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs193026442 | chr3:150541052-150541053 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs556529643 | chr3:150541128-150541129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Blepharophimosis-ptosis-epicanthus inversus syndrome | 22067867 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21364760 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Breast cancer | 16608533 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 16773561 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
abnormal development | 18461090 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Uveal melanoma | 20484589 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:150540200-150541000 | Enhancers | HepG2 | liver |
2 | chr3:150540800-150541600 | Enhancers | Fetal Lung | lung |
3 | chr3:150541000-150541400 | Enhancers | Ovary | ovary |